La Prise en Charge du Cancer du Sein HER2 Positif
| dc.contributor.advisor | OUALLA KARIMA | |
| dc.contributor.author | BELKECHRA Omar | |
| dc.date.accessioned | 2023-09-19T15:08:55Z | |
| dc.date.accessioned | 2026-01-28T15:19:06Z | |
| dc.date.available | 2023-09-19T15:08:55Z | |
| dc.date.issued | 2021 | |
| dc.description.collaborator | MELLAS NAWFEL | |
| dc.description.collaborator | BOUCHIKHI CHAHRAZED | |
| dc.description.collaborator | EL FATEMI HINDE | |
| dc.description.collaborator | ARIFI SAMIA | |
| dc.description.collaborator | OUALLA KARIMA | |
| dc.identifier.uri | https://toubkalpreprod.imist.ma/handle/123456789/24992 | |
| dc.language.iso | FR | |
| dc.publisher | Faculté de Médecine et de Pharmacie, Fès | fr_FR |
| dc.subject | Cancer du sein | fr_FR |
| dc.subject | HER2 positif | fr_FR |
| dc.subject | Facteurs de risques | fr_FR |
| dc.subject | Chimiothérapie | fr_FR |
| dc.subject | Thérapie ciblée | fr_FR |
| dc.subject.other | Oncologie médicale | |
| dc.subject.specific | Oncologie médicale | |
| dc.title | La Prise en Charge du Cancer du Sein HER2 Positif | fr_FR |
Files
Original bundle
1 - 1 of 1